SpineGuard announces its full-year 2020 financial results, first quarter 2021 sales and a flexible financing of €10M
08-April-2021 – 17h45 CE(S)T
Read more SpineGuard reports the end of its French ‘sauvegarde’ proceeding
26-March-2021 – 12h00 CE(S)T
Read more SpineGuard obtains FDA clearance for commercial release of its new “DSG Connect” platform in the USA
15-February-2021 – 11h30 CE(S)T
Read more SpineGuard collaborates with the European project FAROS (Functional Accurate RObotic Surgery)
02-February-2021 – 18h00 CE(S)T
Read more SpineGuard strengthens its intellectual property with a new patent granted in Japan
06-January-2021 – 18h00 CE(S)T
Read more First DSG Connect surgery at Trousseau Hospital in Paris: new milestone of the SpineGuard robotics program
14-December-2020 – 18h00 CE(S)T
Read more
SpineGuard provides updates and perspectives on its ‘safeguard’ and chapter 11 proceedings
18-November-2020 – 18h00 CE(S)T
Read more SpineGuard strengthens its intellectual property with a new patent granted in China
20-October-2020 – 18h00 CE(S)T
Read more SpineGuard announces first surgeries with its new “DSG Connect” platform
29-June-2020 – 8h00 CE(S)T
Read more SpineGuard files its “510K” dossier for the clearance of its new “DSG Connect” platform in the United States
05-June-2020 – 10h00 CE(S)T
Read more SpineGuard strengthens its IP with the grant of three new patents
27-April-2020 – 18h00 CE(S)T
Read more SpineGuard obtains CE mark for commercial release of its new “DSG Connect” platform
02-April-2020 – 08h00 CE(S)T
Read more SpineGuard reports solid improvements in its full-year 2019 financial results
19-March-2020 – 18h00 CE(S)T
Read more SpineGuard initiates safeguard proceedings while adapting its governance to strengthen the development of innovation
14-February-2020 – 08h00 CE(S)T
Read more